ANN ARBOR — A physician-scientist whose work has improved quality of life for tens of thousands of Parkinson’s disease patients is the recipient of the 2015 Taubman Prize for Excellence in Translational Medical Science, the University of Michigan’s A. Alfred Taubman Medical Research Institute announced.
Mahlon DeLong, M.D., professor of neurology at the Emory University School of Medicine, will receive the $100,000 prize in recognition of his contributions to the treatment of Parkinson’s disease.
DeLong is a key faculty leader of The Jean and Paul Amos Parkinson’s Disease and Movement Disorders Research Program. He also is co-director and founder of ENTICe (Emory Neuromodulation and Technology Innovation Center), whose goal is to foster advancement of neuromodulation and the development of innovative neuromodulation technologies for the treatment of neurological and psychiatric disorders.
He is a member of the Institute of Medicine, a fellow of the American Academy of Arts and Sciences, a fellow of the American Association for the Advancement of Science, an elected member of the Johns Hopkins Society of Scholars. He is scientific director of the Dystonia Medical Research Foundation and a member of the Scientific Advisory Board of the American Parkinson Disease Association.
DeLong received his undergraduate degree from Stanford University and his medical degree from Harvard University.